Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
China NMPA Approves MicuRx's Contezolid for Treatment of Drug-Resistant Bacterial Infection 2021-06-03 22:15
Peking University Biologics entering into Strategic Cooperation Agreement with Norwich Investment Limited 2021-06-03 16:29
First Patient Dosed in QBiotics & MSD Clinical Trial Collaboration for Unresectable Melanoma 2021-06-03 06:00
Nanoform raises its mid-term business targets for 2025 2021-06-02 21:42
Shanghai Asclepius Meditec and International Department of Central Committee of CPC Collaborate to Provide Emergency Support to Fight COVID-19 in Nepal 2021-06-02 20:00
Samsung Biologics and KAHR Medical Announce Development and Manufacturing Agreement for Cancer Immunotherapy Drug Candidate 2021-06-02 19:00
New 3M™ Harvest RC clarifier brings chromatography technology to harvest clarification with a single-stage solution for upstream processes 2021-06-02 01:00
Daewoong Pharmaceutical Publishes Results of First Clinical Study of SGLT-2 Inhibitor 'Enavogliflozin' for Canine Diabetes 2021-06-01 21:00
GenScript ProBio and Neoletix signed a letter of intent on clinical and commercial production of recombinant human coagulation factor VIII 2021-06-01 21:00
Positive FDA meetings enable Neuren to proceed with INDs for three Phase 2 trials 2021-06-01 18:00
Scripps Research Institute testing shows Viraleze highly active against UK COVID strain 2021-06-01 17:30
Amgen and Kyowa Kirin to Jointly Develop and Commercialize KHK4083, a Phase 3-Ready, Potential First-In-Class Treatment for Atopic Dermatitis 2021-06-01 16:00
Innovent Biologics and AnHeart Therapeutics Jointly Announce Exclusive License Agreement for Taletrectinib in Greater China 2021-06-01 08:00
Samsung Biologics to add mRNA vaccine drug substance manufacturing suite to expand portfolio of services 2021-05-31 19:00
Moleac Announces US FDA Approval of IND Application for Phase 1 Study of MLC1501 Programme in Post-Traumatic Brain Injury Recovery 2021-05-31 18:33
Hummingbird Bioscience Announces Publication of Abstract on Anti-VISTA Antibody HMBD-002 at the American Society of Clinical Oncology (ASCO) 2021 Annual Meeting 2021-05-31 10:00
Nexturn Bio Inc. acquired a 50% stake in RosVivo Therapeutics, Inc. 2021-05-30 22:00
Dr. Seungpil Yu will hold a retirement ceremony and conclude his 46-year term as a pharmaceutical executive. 2021-05-28 21:00
Samsung Biologics Adds Four Global ISO Certifications For BCMS, Energy, Health & Safety, and Environmental Management 2021-05-28 20:00
CStone Announces the First-in-Class Registrational Clinical Trial of Sugemalimab Met its Primary Endpoint in Stage III NSCLC and Plans to Submit a New Drug Application 2021-05-28 08:10
1 241 242 243 244 245 413